Dr Adrian Draper - Lung Disease Specialist

Dr. Adrian Draper offers consultations on respiratory health at Parkside Hospital on alternate Wednesday mornings and Thursday afternoons. You can also find him at London Bridge Hospital on Friday mornings, where he addresses concerns related to lung cancer. Additionally, he provides services at St Anthony's Hospital on alternate Wednesday mornings.

Dr. Adrian Draper graduated from the University of London. He trained in respiratory and general medicine across various hospitals in London. His research focused on occupational asthma for an MD thesis at Royal Brompton Hospital, and he completed his training at St George’s Hospital, where he was appointed as a consultant physician in 2003.  

In his clinical practice, Dr. Adrian Draper addresses all aspects of lung disease, with a special interest in lung cancer, occupational lung disorders, and interstitial lung diseases. He serves as the clinical director for specialist medicine and is the lead clinician for both respiratory health and lung cancer services at St George’s Hospital. Additionally, he was the chair of the South West London Cancer Network Lung Tumour Working Group until 2012.  

At the end of 2011, together with Mr. I Hunt, Dr. Draper initiated the regional endobronchial ultrasound (EBUS) service at St George’s. This minimally invasive technique is vital for sampling lymph glands to help diagnose and stage lung cancer and other lung conditions.  

Dr. Draper also runs a rapid access clinic at St George’s and has contributed to the development of “near patient tests” through chest ultrasound, enabling safe, rapid investigation of chest disease both in clinics and on the wards. He is an advanced life support instructor for the UK Resuscitation Council and has lectured extensively, contributing to courses in thoracic ultrasound and chest radiology at St George’s Hospital. His involvement in clinical research includes supervising original works that have been presented at national and international meetings.

Peer-reviewed publications by Dr. Adrian Draper and colleagues cover a range of topics in respiratory health and lung cancer. Notable works include: L. Gabriel, T. McVeigh, S. Macmahon, Z. Avila, L. Donovan, I. Hunt, A. Draper, A. Minchom, S. Popat, M. Davidson, J. Bhosle, C. Milner Watts, M. Hubank, L. Yuan, and MER O'Brien's study on familial rare EGFR-mutant lung cancer syndrome, published in Lung Cancer, Volume 191, 2024. O'Dowd E, Berovic M, Callister M, Chalitsios C, Chopra D, Das I, Draper A, and others assessed the impact of an artificial intelligence tool on the management of pulmonary nodules detected incidentally on CT in the DOLCE study protocol, a prospective, non-interventional multicentre UK study published in BMJ Open 2024;14:e077747. Additionally, J May and A Draper explored eosinophilic pneumonia and COVID-19 vaccination in QJM: An International Journal of Medicine, 2022; 115:4 251-252. Mehta M et al. conducted a retrospective case-control study evaluating hypocalcaemia as a distinguishing feature of COVID-19 compared with other infective pneumonias, published in BMJ Open 2021;11: e053810. Aul R, Gates J, Draper A, and others investigated complications after discharge with COVID-19 and the risk factors associated with post-COVID pulmonary fibrosis in Respir Med, 2021 Nov; 188:106602. A Draper*, F Chua* R Vancheeswaran*, T Vaghela, and co-authors focused on early prognostication of COVID-19 to guide hospitalisation versus outpatient monitoring using a point-of-test risk prediction score in Thorax 2021; 76:696-703. Chua F et al. discussed the role of CT in case ascertainment and management of COVID-19 pneumonia in high-incidence regions in The Lancet Respiratory Medicine, 2020 Vol. 8, No. 5, p438–440. Furthermore, G Tunnicliffe and A Draper conducted a pilot study on a digital drainage system in pneumothorax, published in BMJ Open Resp Res 2014;1: e000033. Other significant studies include case reports by Chang YJ, Ali H, and A Draper on unusual causes of cyanosis in COPD patients, and research on unexplained dyspnoea in patients with idiopathic myelofibrosis. Dr. Adrian Draper's extensive research has greatly contributed to the understanding of respiratory health and lung cancer.